PF-05212377
PF-05212377 Uses, Dosage, Side Effects, Food Interaction and all others data.
PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms on Donepezil).
Trade Name | PF-05212377 |
Generic | PF-05212377 |
Type | |
Formula | C18H20N4O2S |
Weight | Average: 356.44 Monoisotopic: 356.130697074 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here PF-05212377